About Event

Welcome to the inaugural Biomarkers for Alzheimer’s Disease Summit

Untitled design (22)

Uncover how specific aspects of the human immune system relate to neurodegeneration and discover different industry biomarker strategies to enable successful development of immuno-neurology targets with INmune Bio and Longevity Therapeutics

Untitled design (22)

Explore new approaches to driving innovation in fluid based biomarkers and discover how exosomes are drivers in AD pathogenesis with, National Institute of Aging (NIH), NeuroDex and Cassava Sciences

Untitled design (22)
Untitled design (22)

Investigate how genetics can inform selection of fluid biomarkers and examine the role of multiplex proteomics for biomarker discovery with Biogen and Tiaki Therapeutics

Map out the path to identifying and validating digital biomarkers to improve treatment outcomes and drive innovation in digital biomarker discovery with Michael J Fox Foundation and Boston University School of Medicine

Untitled design (22)

Hear diverse approaches to implementing biomarkers in clinical therapeutic development in AD with Biogen, Neurodiagnostics, Cyclerion and Alzheon